Vaccine Key Accounts Manager

Glaxosmithkline; City of Middletown (NY); On-site; USD 161,000 - 268,000; Full time

Benefits offered by this job

Health and life insurance

Retirement benefits

Paid holidays and vacation

Parental and caregiver leave

Job summary

GSK is seeking a Vaccine Account Manager to lead B2B customer relationships within large healthcare networks. You will engage C/D-level stakeholders to tailor value propositions and work with field teams to drive vaccine access and formulary outcomes.

This field-based role requires strong account management, contracting know-how, and the ability to navigate complex health systems while delivering growth in the vaccine portfolio.

Qualifications

• Bachelor's Degree from an accredited institution.
• 5+ years combined experience in Pharmaceutical Sales, Pharmaceutical Marketing, Payer and/or Business Development.
• Travel Required: Up to 40% (based on district size)

Responsibilities

• Build partnerships with large-organized customers, incl. HSs, Public Awardees & FQHCs.
• Identify customer objectives/goals and how vaccination efforts can help support.
• Develop robust area Business Plans leading to Good Selling Outcomes (GSO).
• Navigate complex organizational structures to progress on vaccine access/formulary status.
• Collaborate with Public Sector decision makers to address local policy shifts and support field/HQ leadership.
• Conduct comprehensive account reviews and contract performance discussions.

Skills

Account Management

Cross-Functional Work

Data to Insights

Digital Fluency

Omnichannel

Scientific Literacy

Education

Bachelor's Degree

Job description

GSK is seeking a Vaccine Account Manager to lead B2B customer relationships within large healthcare networks. You will engage C/D-level stakeholders to tailor value propositions and work with field teams to drive vaccine access and formulary outcomes.

This field-based role requires strong account management, contracting know-how, and the ability to navigate complex health systems while delivering growth in the vaccine portfolio.